Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Xie, Yuanyuan ^a   Xue, Wei ^a   Shao, Xinghua ^a   Che, Xiajing ^a   Xu, Weijia ^a   Ni, Zhaohui ^a   Mou, Shan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CREATININE; FABP1 PROTEIN, HUMAN; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MEMBRANE PROTEIN; ONCOPROTEIN; VIRUS RECEPTOR;

ACUTE KIDNEY FAILURE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE NEPHROPATHY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; URINALYSIS; BLOOD; COMPLICATION; FOLLOW UP; KIDNEY DISEASES; KIDNEY FUNCTION TEST; MIDDLE AGED; URETERAL OBSTRUCTION; URINE;

ACUTE-PHASE PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; CREATININE; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIPOCALINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; RISK FACTORS; ROC CURVE; URETERAL OBSTRUCTION;

EID: 84911936208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112865     Document Type: Article

References (31)

1. Smith JM, Stablein DM, Munoz R, Hebert D, McDonald RA (2007) Contributions of the transplant registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr Transplant 11: 366-373.
2. Klahr S, Morrissey J (2002) Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283: F861-F875.
3. Chevalier RL, Thornhill BA, Forbes MS, Kiley SC (2010) Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr Nephrol 25: 687-697.
4. Tang X, Lieske JC (2014) Acute and chronic kidney injury in nephrolithiasis. Curr Opin Nephrol Hypertens. 23: 385-390.
5. Dear JW, Yuen PST (2008) Setting the stage for acute-on-chronic kidney injury. Kidney Int 74: 7-9.
6. Ponte B, Felipe C, Muriel A, Tenorio MT, Lian?o F (2008) Long-term functional evolution after an acute kidney injury: a 10-year study. Nephrol Dial Transplant 23: 3859-3866.
7. Siew ED, Ware LB, Ikizler TA (2011) Biological markers of acute kidney injury. J Am Soc Nephrol 22: 810-820.
8. Bonventre JV (2009) Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 24: 3265-3268.
9. Klahr S (1991) New Insights Into the Consequences and Mechanisms of Renal Impairment in Obstructive Nephropathy. Am J Kidney Dis.18: 689.
10. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, et al. (2007) Expressing the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate with Standardized Serum Creatinine Values. Clin. Chem 53: 766-772.
11. Trnka P, Ivanova L, Hiatt MJ, Matsell DG (2012) Urinary Biomarkers in Obstructive Nephropathy. Clin J Am Soc Nephrol 7: 1567-1575.
12. Butt MJ, Tarantal AF, Jimenez DF, Matsell DG (2007) Collecting duct epithelial-mesenchymal transition in fetal urinary tract obstruction. Kidney Int. 72: 936-944.
13. Fu P, Huang XQ, Yuan AH, Yu G, Mei XB, et al. (2012) Effects of salvianolate combined with alprostadil and reduced glutathione on progression of chronic renal failure in patients with chronic kidney diseases: a long-term randomized controlled trial. Journal of Integrative Medicine 10: 641-646.
14. Wasilewska A, Taranta-Janusz K, De?bek W, Zoch-Zwierz W, Kuroczycka- Saniutycz E (2011) KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol 26: 579-586.
15. Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, et al. (2010) Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol. 28: 478-485.
16. Chaturvedi S, Farmer T, Kapke GF (2009) Assay validation for KIM-1: human urinary renal dysfunction biomarker. Int J Biol Sci 5: 128-134.
17. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, et al. (2007) Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 212: 209-217.
18. Xue W, Xie Y, Wang Q, Xu W, Mou S, et al. (2014) Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient. Nephrology 19: 186-194.
19. Portilla D, Dent C, Sugaya T, Nagothu KK, Kundi I, et al. (2008) Liver-type fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 73: 465-472.
20. Kamijo A, Sugaya T, Hikawa A, Okada M, Okumura F, et al. (2004) Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 165: 1243-1255.
21. Nakamura T, Sugaya T, Node K, Ueda Y, Koide H (2006) Urinary excretion of liver-type fatty acid-binding protein in contrast mediun-induced nephropathy. Am J Kidney Dis 47: 439-444.
22. Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, et al. (2005) Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial. J Lab Clin Med 145: 125-133.
23. Mou S, Wang Q, Li J, Shi B, Ni Z (2012) Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis. Clin Chim Acta. 413: 187-191.
24. Xie Y, Xu W, Wang Q, Shao X, Mou S, et al. (2014) Urinary excretion of livertype FABP as a new clinical marker for the progression of obstructive nephropathy. Biomark Med. 8: 543-556.
25. Soni SS, Ronco C, Katz N, Cruz DN (2009) Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif 28: 165-174.
26. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A, et al. (2009) Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 54: 1012-1024.
27. Bhavsar NA, Ko?ttgen A, Coresh J, Astor BC (2012) Neutrophil Gelatinase- Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM-1) as Predictors of Incident CKD Stage 3: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 60: 233-240.
28. Parikh CR, Thiessen-Philbrook H, Garg AX, Kadiyala D, Shlipak MG, et al. (2013) Performance of kidney injury molecule-1 and liver-type fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol. 8: 1079-1088.
29. Shao X, Tian L, Xu W, Zhang Z, Mou S., et al. (2014) Diagnostic Value of Urinary Kidney Injury Molecule 1 for Acute Kidney Injury: A Meta-analysis. PLOS ONE. 9: e84131.
30. Srisawat N, Wen X, Lee M, Kong L, Elder M, et al. (2011) Urinary biomarkers and renal recovery in critically ill patients with renal support. Clin J Am Soc Nephrol. 6: 1815-1823.
31. Han WK, Wagener G, Zhu Y, Wang S, Lee HT (2009) Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephml 4: 873-882.